Lab study reveals patterns of inheritance that defy Mendel’s Laws

Hopkins physicians achieve 95% cure rate for sickle cell disease with bone marrow transplant

A reduced-intensity bone marrow transplant regimen provides durable engraftment with low rejection rates and also may preserve fertility, according to researchers at Johns Hopkins Kimmel Cancer Center.

May 08, 2026

Vol.52 No.18

Clinical Roundup

Inherited long telomeres may drive broad risk for lymphoid cancers, Hopkins-led study finds

Researchers at the Johns Hopkins Kimmel Cancer Center have identified a genetic syndrome in which unusually long telomeres—the protective caps at the ends of chromosomes—allow immune cells to remain biologically “younger” for longer than normal, predisposing affected individuals to lymphoma and other cancers.

May 08, 2026

Vol.52 No.18

Clinical Roundup

Johns Hopkins-led study shows how bacterial toxin drives colon tumor formation

A multicenter research team led by Johns Hopkins Medicine have identified a protein called claudin-4 that binds to the B. fragilis toxin receptor, a toxin which is known to drive colon tumor formation.

April 24, 2026

Vol.52 No.16

Clinical Roundup

Johns Hopkins scientists engineer nanoparticles able to seek and destroy diseased immune cells

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can “educate” the immune system to find and destroy disease-causing cells throughout the body.

March 13, 2026

Vol.52 No.10

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Vasan Yegnasubramanian, MD, PhD, is the director of Precision inHealth Medicine at Johns Hopkins. He spoke with Johns Hopkins Kimmel Cancer Center communications staff about how AI is transforming cancer research and treatment. The transcript of the conversation follows.

March 06, 2026

Vol.52 No.09

By John’s Hopkins Kimmel Cancer Center Communications

Clinical Roundup

Johns Hopkins investigators create open source database to more easily study cancer data

Researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types of cancer data—including laboratory results, genetic sequencing and imaging data—in one setting.

March 06, 2026

Vol.52 No.09

Lab study reveals patterns of inheritance that defy Mendel’s Laws

YOU MAY BE INTERESTED IN

Hopkins physicians achieve 95% cure rate for sickle cell disease with bone marrow transplant

Inherited long telomeres may drive broad risk for lymphoid cancers, Hopkins-led study finds

Johns Hopkins-led study shows how bacterial toxin drives colon tumor formation

Johns Hopkins scientists engineer nanoparticles able to seek and destroy diseased immune cells

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

Johns Hopkins investigators create open source database to more easily study cancer data

Renew today!

Subscriber content

Never miss an issue!

Login